Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
CAS 210302-17-3View product Oral TabletsCertificate pendingSLU-PP-332Price$62.99Formats1 size Compare size options, price, and certificate status before opening the product record
Contraindications and Clinical Cautions While generally safe, growth hormone optimization peptides are contraindicated in patients with active malignancies, as IGF-1 can promote the proliferation of existing cancer cells
All products are made in FDA-registered, cGMP-compliant facilities and third-party tested for purity and potency
Sequential homoharringtonine (HHT) and Interferon (IFN-A) produce high hematologic and cytogenetic response rates in Philadelphia chromosome positive (Ph) chronic myelogenous leukemia (CML)
(2024, July 31)
US$ 24.51
US$ 29.88
US$ 27.47
US$ 21.52
